Abstract  Beta-blockers are a well-known prophylactic treatment for migraine; however, treatment by the ocular route has not been widely
considered. This case illustrates the resolution of a visual field defect associated with migraine and improvement of symptoms
possibly due to administration of a topical beta-blocker. This novel method of treatment especially when visual field defects
are present may have a place in the management of migraine.


Content Type Journal ArticleCategory Case ReportPages 1-4DOI 10.1007/s10792-012-9516-6Authors
Patrick J. T. Chiam, Eye Unit, Stoke Mandeville Hospital, Aylesbury, Buckinghamshire HP21 8AL, UK



Journal International OphthalmologyOnline ISSN 1573-2630Print ISSN 0165-5701 (Source: International Ophthalmology)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

More...